MARKET

QURE

QURE

Uniqure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

61.97
+0.79
+1.29%
Opening 14:19 01/29 EST
OPEN
61.58
PREV CLOSE
61.18
HIGH
63.15
LOW
61.00
VOLUME
179.41K
TURNOVER
--
52 WEEK HIGH
82.49
52 WEEK LOW
31.75
MARKET CAP
2.70B
P/E (TTM)
-22.6755
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of QURE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

QURE News

  • Revisiting uniQure
  • Seeking Alpha - Article.5d ago
  • Cantor Fitzgerald Maintains Overweight on uniQure, Raises Price Target to $96
  • Benzinga.6d ago
  • Cambridge startup raises $110M for re-doseable gene therapies
  • American City Business Journals.01/10 19:20
  • uniQure (NASDAQ:QURE) Shareholders Have Enjoyed A Magnificent 1077% Share Price Gain
  • Simply Wall St..01/07 17:12

More

Industry

Biotechnology & Medical Research
-0.01%
Pharmaceuticals & Medical Research
+0.40%

Hot Stocks

Name
Price
%Change

About QURE

Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
More

Webull offers Uniqure NV (QURE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.